Forum Archive Index - March 2000

["Mark & Sharyn Tilley" <o.tilley@xtra.co.nz>]

Nick,

Nufarm is suffering from its orphan status after its move from NZ.  The road
to recovery may take a little longer than anticipated as Nufarm strives to
build up investor interest in Australia.  NUF has recently exited the
Chinese pharmaceutical market which may account for some weakness.  I
believe the company holds excellent value at current levels and I rate the
true value of the shares at around $6.50.  As with any investment,
especially in a new country, NUF will need to demonstrate results before the
true value of the company is realised.  Stick in there if you are able.

Cheers

Mark Tilley
----- Original Message -----
From: "nick" <acummin@es.co.nz>
To: <sharechat@sharechat.co.nz>
Sent: Wednesday, March 01, 2000 8:33 AM
Subject: [sharechat] Nufarm: Help!!!!!


>        Whats happening here?
>  I bought into nufarm last year at 5.50 when it looked
> to be heading towards 7.00.  When the slide began i
> bought again at 4.20, now its down to 3.35, is there any
> end to this drop?
>                  Yesterday they announced buying a genetic research
> outfit, whiich seems to have increased the decl8ine in share price.
>          Im trying to convince myself the large falls have been due
> to investors pulling out due to australia move, combined with weak
> stock prices generally. I keep expecting the stock to bottom and then
> begin its march back up the price charts.
>         Am i missing something here?.
>
>   nick
>
>
>
> --------------------------------------------------------------------------
--
> http://www.sharechat.co.nz/          New Zealand's home for market
investors
> To remove yourself from this list, please us the form at
> http://www.sharechat.co.nz/forum.html.


----------------------------------------------------------------------------
http://www.sharechat.co.nz/          New Zealand's home for market investors
To remove yourself from this list, please us the form at
http://www.sharechat.co.nz/forum.html.